Loading clinical trials...
Loading clinical trials...
Precision Neuromodulation in Post-Stroke Aphasia Using TMS
The investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).
In this project, the investigator will use functional neuroimaging and inhibitory TMS to determine precise therapy-responsive targets for excitatory TMS therapy with SFA. One group of stroke survivors will receive SFA + TMS targeting the precision site, and another group will receive SFA + TMS targeting a control site. The primary outcome will be changes in picture naming accuracy. We expect that excitatory TMS targeting a precision site would result in larger improvements in naming accuracy than TMS targeting a control site. Results will provide the efficacy of precision TMS in post-stroke aphasia.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Start Date
September 1, 2025
Primary Completion Date
December 31, 2036
Completion Date
December 31, 2036
Last Updated
September 19, 2025
50
ESTIMATED participants
Precision TMS with SFA
DEVICE
Control TMS with SFA
DEVICE
Lead Sponsor
Medical College of Wisconsin
NCT05093673
NCT06258538
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07371455